Literature DB >> 8216721

HIV and human complement: mechanisms of interaction and biological implication.

M P Dierich1, C F Ebenbichler, P Marschang, G Füst, N M Thielens, G J Arlaud.   

Abstract

Human complement, although not lytic for HIV-1, interacts with the virus and is closely involved in the infectious process. It enhances infection in the absence of antibody, and turns neutralizing antibodies into agents which increase viral infectivity. In this review M.P. Dierich et al. summarize available information and discuss possible biological implications.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8216721     DOI： 10.1016/0167-5699(93)90246-H

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  11 in total

1.  B lymphocytes in lymph nodes and peripheral blood are important for binding immune complexes containing HIV-1.

Authors:  J J Jakubik; M Saifuddin; D M Takefman; G T Spear
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

2.  Studies on the mechanism of complement-mediated inhibition of antibody binding to HIV gp41.

Authors:  T Hidvégi; Z Prohászka; E Ujhelyi; N M Thielens; M P Dierich; H Hampl; G Arlaud; K Nagy; G Füst
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

Review 3.  Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.

Authors:  N Chirmule; S Pahwa
Journal:  Microbiol Rev       Date:  1996-06

4.  Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59.

Authors:  J Schmitz; J P Zimmer; B Kluxen; S Aries; M Bögel; I Gigli; H Schmitz
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

5.  Human serum protein enhances HIV-1 replication and up-regulates the transcription factor AP-1.

Authors:  Maria F Perdomo; Waltteri Hosia; Alenka Jejcic; Garry L Corthals; Anders Vahlne
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-09       Impact factor: 11.205

6.  Efficacy of HIV-specific and 'antibody-independent' mechanisms for complement activation by HIV-infected cells.

Authors:  M N Saarloos; T F Lint; G T Spear
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

7.  Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression.

Authors:  L Chakrabarti; M C Cumont; L Montagnier; B Hurtrel
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  Blocking measles virus infection with a recombinant soluble form of, or monoclonal antibodies against, membrane cofactor protein of complement (CD46).

Authors:  T Seya; M Kurita; T Hara; K Iwata; T Semba; M Hatanaka; M Matsumoto; Y Yanagi; S Ueda; S Nagasawa
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

9.  Increased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus infection.

Authors:  O Lund; J Hansen; A M Søorensen; E Mosekilde; J O Nielsen; J E Hansen
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease.

Authors:  Jing Qin Wu; Dominic E Dwyer; Wayne B Dyer; Yee Hwa Yang; Bin Wang; Nitin K Saksena
Journal:  Retrovirology       Date:  2011-03-16       Impact factor: 4.602
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.